In a tauP301L mouse model of Alzheimer’s disease, Au-PEG treatment reduced circulating tau levels in the serum, suggesting its potential to limit tau propagation to neighboring neurons and other CNS cells. The gene discussed is MAPT; the disease is Alzheimer disease.